BusinessSun Pharma Elevates Aalok Shanghvi As Chief Operating Officer
ADVERTISEMENT
Sun Pharma Elevates Aalok Shanghvi As Chief Operating Officer
Aalok Shanghvi is currently designated as Whole-time Director and Executive Vice-President, Emerging Markets, Global Generic R&D, Global Business Development (Generics), Operations and API.
Shanghvi, son of Sun Pharma MD Dilip Shanghvi, joined Sun Pharma in 2006. (Photo source: Sun Pharmaceutical Industries/Facebook)
Sun Pharmaceutical Industries Ltd. on Monday said it has elevated Aalok Shanghvi as Chief Operating Officer.
He is currently designated as Whole-time Director and Executive Vice-President, Emerging Markets, Global Generic R&D, Global Business Development (Generics), Operations and API.
Shanghvi, son of Sun Pharma Managing Director Dilip Shanghvi, joined Sun Pharma in 2006 and has handled various roles in marketing, R&D, project management, purchase and communications, the Mumbai-based drug major said in a regulatory filing.
In 2014, he became the Head of Emerging Markets business, spread across 80 countries covering Africa, the Middle East, APAC, Eastern Europe, CIS, and Latam.